Two Sigma Advisers
TRIB

Two Sigma Advisers’s Trinity Biotech TRIB Stock Holding History

Two Sigma Advisers’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,060
Closed -$30K – 2672
2021
Q2 		$30K Sell
2,060
-1,340
-39% -$22.3K ﹤0.01% 2401
2021
Q1 		$64K Sell
3,400
-1,540
-31% -$37K ﹤0.01% 2483
2020
Q4 		$94K Buy
+4,940
New +$81.7K ﹤0.01% 2276
2020
Q3 		– Sell
-3,960
Closed -$43K – 2631
2020
Q2 		$43K Sell
3,960
-2,140
-35% -$16.3K ﹤0.01% 2434
2020
Q1 		$34K Sell
6,100
-480
-7% -$2.51K ﹤0.01% 2395
2019
Q4 		$34K Hold
6,580
– – ﹤0.01% 2302
2019
Q3 		$40K Hold
6,580
– – ﹤0.01% 2163
2019
Q2 		$54K Hold
6,580
– – ﹤0.01% 2251
2019
Q1 		$94K Sell
6,580
-220
-3% -$3.02K ﹤0.01% 2197
2018
Q4 		$78K Hold
6,800
– – ﹤0.01% 2241
2018
Q3 		$136K Sell
6,800
-340
-5% -$7.39K ﹤0.01% 2132
2018
Q2 		$179K Hold
7,140
– – ﹤0.01% 2218
2018
Q1 		$184K Sell
7,140
-1,140
-14% -$31.1K ﹤0.01% 2162
2017
Q4 		$212K Sell
8,280
-1,800
-18% -$46.4K ﹤0.01% 2072
2017
Q3 		$283K Sell
10,080
-968
-9% -$27K ﹤0.01% 1948
2017
Q2 		$331K Sell
11,048
-5,052
-31% -$143K ﹤0.01% 1949
2017
Q1 		$480K Sell
16,100
-7,540
-32% -$236K ﹤0.01% 1914
2016
Q4 		$818K Buy
23,640
+15,700
+198% +$541K ﹤0.01% 1650
2016
Q3 		$525K Sell
7,940
-980
-11% -$61K ﹤0.01% 1664
2016
Q2 		$506K Sell
8,920
-5,360
-38% -$302K ﹤0.01% 1513
2016
Q1 		$833K Sell
14,280
-2,320
-14% -$123K ﹤0.01% 1214
2015
Q4 		$976K Buy
16,600
+6,880
+71% +$406K 0.01% 1030
2015
Q3 		$576K Sell
9,720
-120
-1% -$9.65K ﹤0.01% 1243
2015
Q2 		$889K Buy
9,840
+5,160
+110% +$447K 0.01% 1171
2015
Q1 		$450K Sell
4,680
-1,220
-21% -$113K ﹤0.01% 1399
2014
Q4 		$517K Buy
+5,900
New +$508K ﹤0.01% 1603

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's TRIB Position: Q3 2021 in Review

Two Sigma Advisers sold out of Trinity Biotech (TRIB) in Q3 2021, closing a stake of 2,060 shares — an estimated $30K sold.

Two Sigma Advisers first reported a position in TRIB in Q4 2014 and held it in 26 quarters. The position peaked at $976K in Q4 2015. 22 funds tracked by Wall St. Rank hold TRIB as of Q3 2021.

  • Two Sigma Advisers reported no remaining Trinity Biotech position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 2,060 Trinity Biotech shares in Q3 2021, an estimated $30K.
  • Two Sigma Advisers first reported a position in Trinity Biotech in Q4 2014 and held it in 26 quarters.
  • Two Sigma Advisers's Trinity Biotech position peaked at $976K in Q4 2015.
  • 22 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.